Establishment Labs Holdings ROE 2017-2018 | ESTA

Current and historical return on equity (ROE) values for Establishment Labs Holdings (ESTA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Establishment Labs Holdings ROE for the three months ending September 30, 2018 was -173.53%.
Establishment Labs Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $-0.02B $0.08B -110.77%
2018-06-30 $-0.03B $0.00B 1000.00%
2018-03-31 $-0.04B $-0.01B 1057.14%
2017-12-31 $-0.04B $-0.01B 2800.00%
2017-09-30 $-0.03B $0.00B 430.77%
Sector Industry Market Cap Revenue
Medical Medical Services $0.516B $0.035B
Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.792B 24.42
PRA Health Sciences (PRAH) United States $7.283B 29.73
Charles River Laboratories (CRL) United States $6.737B 23.21
NovoCure (NVCR) Jersey $4.888B 0.00
Premier (PINC) United States $4.816B 16.33
HealthEquity (HQY) United States $4.728B 92.42
Teladoc (TDOC) United States $4.668B 0.00
AMN Healthcare Services Inc (AMN) United States $3.046B 19.76
BioTelemetry (BEAT) United States $2.531B 44.71
Medpace Holdings (MEDP) United States $2.434B 30.11
Intrexon (XON) United States $1.040B 0.00
Natera (NTRA) United States $1.000B 0.00
CareDx (CDNA) United States $0.933B 0.00
Healthways (TVTY) United States $0.846B 10.41
China Cord Blood (CO) China $0.817B 22.40
Apollo Medical Holdings (AMEH) United States $0.651B 0.00
Civitas Solutions (CIVI) United States $0.643B 10.61
Surgery Partners (SGRY) United States $0.641B 0.00
OncoCyte (OCX) United States $0.198B 0.00
Imprimis Pharmaceuticals (HROW) United States $0.143B 0.00
Interpace Diagnostics (IDXG) United States $0.027B 0.00
OpGen (OPGN) United States $0.012B 0.00
Cancer Genetics (CGIX) United States $0.007B 0.00
FORM Holdings (XSPA) United States $0.006B 0.00
Biocept (BIOC) United States $0.002B 0.00